NF1

Clinical trials for NF1 explained in plain language.

Never miss a new study

Get alerted when new NF1 trials appear

Sign up with your email to follow new studies for NF1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 4

New drug cocktail takes on rare nerve tumors

Disease control Not yet recruiting

This early-phase trial tests a combination of three drugs—selumetinib, ZEN-3694, and durvalumab—in people with advanced sarcomas, including malignant peripheral nerve sheath tumors (MPNST) linked to NF1. The study first checks safety and dosing, then looks at whether the treatmen…

Matched conditions: NF1

Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

NF1

Get alerted when new NF1 trials appear

New drug cocktail takes on rare nerve tumors